(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENOSCORE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENOSCORE

ST13

US500000079350679

Class

42, 44

Filing

79350679

Registration

7307296

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

07/27/2024

Trademark type

Word

Nice classes

42, 44

Filing date

05/11/2022

Registration date

02/20/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/20/2024

Last transaction

02/20/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

HUSSAIN, TASNEEM

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cytox Limited

Representatives

Sean D. Detweiler Morse, Barnes-Brown & Pendleton, P.C.

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Software as a service services featuring software for use in early diagnosis of degenerative diseases; advisory services relating to genetic science; analysis of human tissues for medical research; biochemical researchdevelopment and analysis; biological researchdevelopment and analysis; biotechnological researchdevelopment and analysis; chemical research and analysis; clinical research in the field of degenerative diseases; consultancy relating to laboratory genetic testing for research purposes; laboratory research in the field of degenerative diseases; medical laboratory services; medical research; providing temporary use of non-downloadable computer software for accessing and using a cloud computing network; providing temporary use of web-based non-downloadable software for use in early diagnosis of degenerative diseases; providing temporary use of non-downloadable computer software; research and development services in the field of gene expression systems; providing temporary use of online non-downloadable computer software to aid early diagnosis of degenerative diseases; providing temporary use of online non-downloadable computer software to aid early diagnosis of progressive diseases; software as a service to aid early diagnosis of degenerative diseases; software as a service services featuring software to aid early diagnosis of progressive diseases; scientific risk assessmentreviewing scientific data and studies and prediction and assessment of human health risks in the field of degenerative diseases

Class 44

Medical testing for diagnostic or treatment purposes; medical diagnostic testingmonitoring and reporting services; medical treatment services; cognitive therapy services; cognitive and psychological examination and testing services; informationadvice and consultancy in relation to all the aforesaid services; all the aforesaid being in the fields of dementia and cognitive decline

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/27/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/09/2024

FIMP

FINAL DISPOSITION PROCESSED

07/09/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/20/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/05/2023

PUBO

PUBLISHED FOR OPPOSITION

12/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/03/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/15/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/15/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/30/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/20/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/20/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/20/2023

RFNT

REFUSAL PROCESSED BY IB

05/17/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/25/2023

RFRR

REFUSAL PROCESSED BY MPU

04/25/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/03/2023

CNRT

NON-FINAL ACTION WRITTEN

03/02/2023

DOCK

ASSIGNED TO EXAMINER

03/01/2023

MAFR

APPLICATION FILING RECEIPT MAILED

09/30/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/26/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/22/2022

Continuous trademark protection

Get notified about every new filing that threatens GENOSCORE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.